Triclosan-impregnated sutures to decrease surgical site infections: Systematic review and meta-analysis of randomized trials

Annals of Surgery

Volumn 255, Issue 5, 2012, Pages 854-859

  Chang, Wai Keat ^a   Srinivasa, Sanket ^a   Morton, Randall ^a   Hill, Andrew G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

TRICLOSAN;

COCHRANE LIBRARY; EMBASE; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHUNT INFECTION; SURGICAL INFECTION; SUTURE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS, LOCAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL WOUND INFECTION; SUTURES; TRICLOSAN; WOUND HEALING;

EID: 84859906671     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31824e7005     Document Type: Review

References (55)

1. Leaper DJ. Surgical-site infection. Br J Surg. 2010;97:1601-1602.
2. Hranjec T, Swenson R, Sawyer RG. Surgical site infection prevention: how we do it. Surg Infect. 2010;11:289-294.
3. Kirkland KB,Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization and extra cost. Infect Control Hosp Epidemiol. 1999;20:725-730.
4. Geubbels EL, Mintjes-de Groot AJ, Van den Berg JM, et al. An operating surveillance system of surgical site infections in the Netherlands: results of the PREZIES national surveillance network. Preventie van Ziekenhuisinfecties door Surveillance. Infect Control Hosp Epidemiol. 2000;21:311-318.
5. Coello R, Glenister H, Fereres J, et al. The cost of infection in surgical patients: a case-control study. J Hosp Infect. 1993;24:239-250. (Pubitemid 24042248)
6. Fry DE. The economic cost of surgical site infection. Surg Infect. 2002;3 (supp 1):S37-S42.
7. Humphreys H. Preventing surgical site infection. Where now? J Hosp Infect. 2009;73:316-322.
8. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592-598. (Pubitemid 36259564)
9. Centers for Medicare and Medicaid Services.Quality Measures for reporting in fiscal year 2009 for 2010 update. Available at: www.cms.gov.gov/apps/media/ press/factsheet.asp. Accessed September 28, 2010.
10. Deficit Reduction Act of 2005. Available at: http://www.gpo.gov/fdsys/ pkg/PLAW-109publ171/pdf/PLAW-109publ171.pdf. Accessed September 28, 2010.
11. Centers for Medicare and Medicaid Services. CMS improves patient safety for Medicare and Medicaid by addressing never events. Available at: www.cms. gov.gov/apps/media/press/factsheet.asp. Accessed on: September 28, 2010.
12. National Institute for Health and Clinical Excellence. Surgical Site Infection, Prevention and Treatment of Surgical Site Infection. London, UK: National Collaborating Centre for Women's and Children's Health; 2008.
13. Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 (suppl 1):S51-S61.
14. Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evaluation of national quality measures. Surg Infect. 2008:9: 579-584.
15. Katz S, IzharM,MirelmanD.Bacterial adherence to surgical sutures: a possible factor in suture induced infection. Ann Surg. 1981;194:35-41. (Pubitemid 12197147)
16. Gristina AG, Price JL, Hobgood CD, et al. Bacterial colonization of percutaneous sutures. Surgery. 1985;98:12-19. (Pubitemid 16136513)
17. Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man: a study of the problems of wound infection. Br J Exp Pathol. 1957;38: 573-586.
18. Glassman JA, Fowler EF, Novak MV: An experimental study of sulfonamide impregnated sutures. Surg Gynecol Obstet. 1944;78:359-363.
19. US Food and Drug Administration. Summary of safety and effectiveness QEc 1.9 2002. Available at: http://www.accessdata.fda.gov/cdrh docs/pdf2/k022715. pdf. Accessed September 28, 2010.
20. Jones RD, Jampani HB, Newman JL, et al. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control. 2000;28:184-196. (Pubitemid 30226494)
21. Barbolt T. Chemistry and safety of triclosan, and its use as an antimicrobial coating on Coated Vicryl Plus Antibacterial suture. Surg Infect. 2002;3: S45-S53.
22. Leaper D, McBain AJ, Kramer A, et al. Healthcare associated infection: novel strategies and antimicrobial implants to prevent surgical site infection. Ann R Coll Surg Engl. 2010;92:453-458.
23. Antibacterial Sutures for Wound Closure After Surgery: Clinical Effectiveness and Guidelines forUse.Ottawa,Canada: Canadian Agency forDrugs and Technologies in Health (CADTH); 2010. Available at: http://www.cadth.ca/media/ pdf/l0204 anti-bacterial sutures htis 2.pdf. Accessed September 28, 2010.
24. Deliaert AE, Kerckhove EV, Tuinder S, et al. The effect of triclosan-coated sutures in wound healing: a double blind randomised prospective pilot study. J Plast Reconstr Aesthet Surg. 2009;62:771-773.
25. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration, 2008. Available at: www. cochrane-handbook.org. Accessed September 26, 2010.
26. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8: 336-341.
27. Current Controlled trials. Available at: http://www.controlled-trials. com/mrct. Accessed September 26, 2010.
28. ClinicalTrials.gov. Available at: http://clinicaltrials.gov. Accessed on September 26, 2010.
29. Rozelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double blind, randomized controlled trial. J Neurosurg Pediatrics. 2008;2:111-117.
30. Mingmalairak C, Ungbhakorn P, Paocharoen V. Efficacy of antimicrobial coating suture coated Polyglactin 910 with Triclosan (Vicryl Plus) compared with Polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. J Med Assoc Thai. 2009;92:770-775.
31. Ford HR, Jones P, Gaines B, et al. Intraoperative handling and wound healing: controlled clinical trial comparing coated Vicryl Plus antibacterial suture (coated Polyglactin 910 suture with Triclosan) with coated Vicryl suture (coated Polyglactin 910 suture). Surg Infect. 2005;6:313-321. (Pubitemid 41645597)
32. Defazio A, Datta M, Nezhat C. Does the use of Vicryl Plus antibacterial suture decrease the incidence of umbilical infection when compared to Vicryl suture? Fertil Steril. 2005;84(suppl 1):S161.
33. ClinicalTrials.gov. Abdominal wall closure with triclosan-coated suture (TCS09-10). Available at: http://clinicaltrials.gov/ct2/show/NCT01123616. Accessed September 26, 2010.
34. ClinicalTrials.gov. Coated VICRYL Plus suture compared to Chinese silk in scheduled breast cancer surgery. Available at http://clinicaltrials.gov/ct2/ show/NCT00768222. Accessed September 26, 2010.
35. Storch M, Rothenburger S, Jacinto G. Experimental efficacy study of coated Vicryl plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect. 2004;5:281-288. (Pubitemid 39462171)
36. Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt). 2008;9:451-457.
37. Gomez-Alonso A, Garcia-Criado FJ, Parreno-Manchado FC, et al. Study of the efficacy of Coated VICRYL Plus Antibacterial Suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery. J Infect. 2007;54:82-88. (Pubitemid 44932941)
38. Rothenburger S, Spangler D, Bhende S, et al. In vitro antimicrobial evaluation of coated Vicryl Plus antibacterial suture (coated Polyglactin 910 with Triclosan) using zone inhibition assays. Surg Infect. 2002;3: S79-S87.
39. Edmiston CE, Seabrook GR, Goheen MP, et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg. 2006;203:481-489. (Pubitemid 44416259)
40. Marco F, Vallez R, Gonzalez P, et al. Study of the efficacy of coated Vicryl Plus antibacterial suture in an animalmodel of orthopaedic surgery. Surg Infect. 2007;8:359-365. (Pubitemid 47186306)
41. Justinger C, Moussavian MR, Schlueter C, et al. Antibiotic coating of abdominal closure sutures and wound infection. Surgery. 2009;145:330-334.
42. Fleck T, Moidl R, Blacky A, et al. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg. 2007;84:232-236. (Pubitemid 46921148)
43. Mangram AJ, Horan TC, PearsonML, et al. Hospital infection control practice advisory committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20:247-278.
44. Storch M, Scalzo H, Van Lue S, et al. Physical and functional comparison of coated Vicryl Plus antibacterial suture (coated Polyglactin 910 suture with Triclosan) with coated Vicryl suture (coated Polyglactin 910 suture). Surg Infect. 2002;3:S65-S77.
45. SullerMTE, Russell AD. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother. 2000;46:11-18.
46. Mcdonnell G, Pretzer D. Action and targets of triclosan. SAM News. 1998;64:670-671.
47. Gilbert P, McBain AJ. Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with Triclosan. Surg Infect. 2002;3:S55-S63.
48. Podariu AC, Galuscan A, Roianu RS. The innocuity of triclosan: a review. Timisoa Med J. 2009;60:90-93.
49. Barkun JS, Aronson JK, Feldman LS, et al. Evaluation and stages of surgical innovations. Lancet. 2009;374:1089-1096.
50. Ergina PL, Cook JA, Blazeby JM, et al. Challenges in evaluating surgical innovation. Lancet. 2009;374:1097-1104.
51. McCulloch P, Altman DG, Campbell WB, et al. No surgical innovationwithout evaluation: the IDEAL recommendations. Lancet. 2009;374:1105-1112.
52. Dersimonian R, Carette LJ, McPeek B, et al. Reporting on methods in clinical trials. N Engl J Med. 1982;306:1332-1337. (Pubitemid 12105160)
53. Sacks HS, Berrier J, Reitman D, et al.Meta-analyses of randomized controlled trials. N Engl J Med. 1987;316:450-455. (Pubitemid 17035572)
54. Imperiale TE. Meta-analysis: When and how. Hepatology. 1999;29 (suppl 1):26S-31S.
55. Zargar-Shoshtari K, Connolly AB, Israel LH, et al. Fast-Track surgery may reduce complications following major colonic surgery. Dis Col Rect. 2008;51:1633-1640.